Polymodal activation of the endocannabinoid system in the extended amygdala

Nat Neurosci. 2011 Nov 6;14(12):1542-7. doi: 10.1038/nn.2974.

Abstract

The reason why neurons synthesize more than one endocannabinoid (eCB) and how this is involved in the regulation of synaptic plasticity in a single neuron is not known. We found that 2-arachidonoylglycerol (2-AG) and anandamide mediate different forms of plasticity in the extended amygdala of rats. Dendritic L-type Ca(2+) channels and the subsequent release of 2-AG acting on presynaptic CB1 receptors triggered retrograde short-term depression. Long-term depression was mediated by postsynaptic mGluR5-dependent release of anandamide acting on postsynaptic TRPV1 receptors. In contrast, 2-AG/CB1R-mediated retrograde signaling mediated both forms of plasticity in the striatum. These data illustrate how the eCB system can function as a polymodal signal integrator to allow the diversification of synaptic plasticity in a single neuron.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonic Acids / metabolism
  • Biophysics
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / metabolism
  • Calcium Channels, L-Type / ultrastructure
  • Cannabinoid Receptor Modulators / metabolism*
  • Cannabinoid Receptor Modulators / pharmacology
  • Chromones / pharmacology
  • Cyclohexanones / pharmacology
  • Electric Stimulation
  • Endocannabinoids*
  • Enzyme Inhibitors / pharmacology
  • Excitatory Amino Acid Antagonists / pharmacology
  • Glycerides / metabolism
  • In Vitro Techniques
  • Long-Term Synaptic Depression / drug effects
  • Long-Term Synaptic Depression / physiology
  • Neurons / drug effects
  • Neurons / physiology*
  • Neurons / ultrastructure
  • Nimodipine / pharmacology
  • Patch-Clamp Techniques
  • Piperidines / pharmacology
  • Pyrazoles / pharmacology
  • Pyridines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Cannabinoid, CB2 / metabolism
  • Receptor, Cannabinoid, CB2 / ultrastructure
  • Receptor, Metabotropic Glutamate 5
  • Receptors, Metabotropic Glutamate / metabolism
  • Receptors, Metabotropic Glutamate / ultrastructure
  • Septal Nuclei / cytology*
  • Septal Nuclei / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Synapses / metabolism
  • Synapses / ultrastructure
  • TRPV Cation Channels / metabolism
  • TRPV Cation Channels / ultrastructure
  • Time Factors

Substances

  • 7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl ester
  • Arachidonic Acids
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Cannabinoid Receptor Modulators
  • Chromones
  • Cnr2 protein, rat
  • Cyclohexanones
  • Endocannabinoids
  • Enzyme Inhibitors
  • Excitatory Amino Acid Antagonists
  • Glycerides
  • Grm5 protein, rat
  • L-type calcium channel alpha(1C)
  • Piperidines
  • Pyrazoles
  • Pyridines
  • Receptor, Cannabinoid, CB2
  • Receptor, Metabotropic Glutamate 5
  • Receptors, Metabotropic Glutamate
  • TRPV Cation Channels
  • Trpv1 protein, rat
  • AM 251
  • Nimodipine
  • 6-methyl-2-(phenylethynyl)pyridine
  • 1,6-bis(cyclohexyloximinocarbonyl)hexane
  • glyceryl 2-arachidonate
  • Calcium